Si tienes 25 años o menos y un diagnóstico (o síntomas) de endometriosis, acompañanos este sábado, desde las 9:30am, para una mañana para apoyarnos y conocernos a nosotras mismas. Compartiremos experiencias y nos apoyaremos unas a otras, además de poder participar en un taller de motivación especialmente diseñado para chicas en este grupo de edad.
Para más informacion escribenos a endopr@gmail.com o llama al 787-840-2575 x2611, 2192, 2177.
SAN DIEGO, May 24 /PRNewswire-FirstCall/ — Neurocrine Biosciences, Inc. today announced statistically significant and clinically meaningful top-line efficacy results from its Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
“The Daisy PETAL study was successful, all primary and secondary efficacy endpoints were met, and provided exactly the information we need to move this program forward,” said Chris O’Brien, M.D., Chief Medical Officer at Neurocrine. “We now have confirmation that the daily scales for menstrual and non-menstrual pelvic pain, developed with extensive input from the FDA and patients, function well in a clinical trial setting. These daily endpoints reflect the way women with endometriosis experience their symptoms and also demonstrate improvement with elagolix.”
More info: http://www.biospace.com/news_story.aspx?NewsEntityId=181728
Sabinadas y Serraterias – Tributo a Joaquín Sabina & Joan Manuel Serrat
Presentado por: Silverio Pérez y Mikie Rivera
Fecha: Sábado, 24 de abril de 2010
Hora: 8:00 PM
Lugar: Centro de Bellas Artes Ada E. Mage, Juana Díaz, Puerto Rico
Esta actividad es pro-fondos para la fundación (se donara $2.00 de cada boleto).